Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) two randomised, double-masked,...

Heier Jeffrey S., Khanani Arshad M., Ruiz Carlos Quezada, Basu Karen, Ferrone Philip J., Brittain Christopher, Figueroa Marta S., Lin Hugh, Holz Frank G., Patel Vaibhavi, Lai Timothy Y. Y., Silverman David, Tóth-Molnár Edit, Zatorska Barbara, Kollaborációs szervezet: TENAYA and LUCERNE Investigators
2022

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2) 12-month results from a randomised, double-masked, phase 3 trial /

Khanani Arshad M, Patel Sunil S, Staurenghi Giovanni, Tadayoni Ramin, Danzig Carl J, Eichenbaum David A, Hsu Jason, Wykoff Charles C, Heier Jeffrey S, Lally David R, Monés Jordi, Nielsen Jared S, Sheth Veeral S, Kaiser Peter K, Clark Julie, Zhu Liansheng, Patel Hersh, Tang Justin, Desai Dhaval, Jaffe Glenn J, Kollaborációs szervezet: GATHER2 trial investigators, Tóth-Molnár Edit
2023